These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 23245509)
21. Circulating adhesion molecules in apoE-deficient mouse strains with different atherosclerosis susceptibility. Tian J; Pei H; James JC; Li Y; Matsumoto AH; Helm GA; Shi W Biochem Biophys Res Commun; 2005 Apr; 329(3):1102-7. PubMed ID: 15752767 [TBL] [Abstract][Full Text] [Related]
22. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice. Jiang H; Li X; Zhang X; Liu Y; Huang S; Wang X Cardiovasc Pathol; 2014; 23(3):169-74. PubMed ID: 24561077 [TBL] [Abstract][Full Text] [Related]
23. TRIM65 Suppresses oxLDL-induced Endothelial Inflammation by Interaction with VCAM-1 in Atherogenesis. Ma XF; Zhou YR; Zhou ZX; Liu HT; Zhou BB; Deng NH; Zhou K; Tian Z; Wu ZF; Liu XY; Fu MG; Jiang ZS Curr Med Chem; 2024; 31(30):4898-4911. PubMed ID: 37608612 [TBL] [Abstract][Full Text] [Related]
24. Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient mice. Preusch MR; Bea F; Yang SH; Kreuzer J; Isermann B; Pedal I; Rosenfeld ME; Katus HA; Blessing E J Cardiovasc Pharmacol; 2007 Aug; 50(2):206-12. PubMed ID: 17703138 [TBL] [Abstract][Full Text] [Related]
25. Viscolin reduces VCAM-1 expression in TNF-α-treated endothelial cells via the JNK/NF-κB and ROS pathway. Liang CJ; Wang SH; Chen YH; Chang SS; Hwang TL; Leu YL; Tseng YC; Li CY; Chen YL Free Radic Biol Med; 2011 Oct; 51(7):1337-46. PubMed ID: 21767632 [TBL] [Abstract][Full Text] [Related]
26. Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice. Matsumoto M; Sata M; Fukuda D; Tanaka K; Soma M; Hirata Y; Nagai R Atherosclerosis; 2008 Apr; 197(2):524-33. PubMed ID: 17765904 [TBL] [Abstract][Full Text] [Related]
27. Functional blockage of EMMPRIN ameliorates atherosclerosis in apolipoprotein E-deficient mice. Liu H; Yang LX; Guo RW; Zhu GF; Shi YK; Wang XM; Qi F; Guo CM; Ye JS; Yang ZH; Liang X Int J Cardiol; 2013 Oct; 168(4):3248-53. PubMed ID: 23642811 [TBL] [Abstract][Full Text] [Related]
28. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice. Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640 [TBL] [Abstract][Full Text] [Related]
29. Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice. Justicia C; Martín A; Rojas S; Gironella M; Cervera A; Panés J; Chamorro A; Planas AM J Cereb Blood Flow Metab; 2006 Mar; 26(3):421-32. PubMed ID: 16079786 [TBL] [Abstract][Full Text] [Related]
30. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice. Danzaki K; Matsui Y; Ikesue M; Ohta D; Ito K; Kanayama M; Kurotaki D; Morimoto J; Iwakura Y; Yagita H; Tsutsui H; Uede T Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):273-80. PubMed ID: 22116098 [TBL] [Abstract][Full Text] [Related]
31. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression. Morris-Rosenfeld S; Blessing E; Preusch MR; Albrecht C; Bierhaus A; Andrassy M; Nawroth PP; Rosenfeld ME; Katus HA; Bea F Eur J Clin Invest; 2011 Nov; 41(11):1164-71. PubMed ID: 21418204 [TBL] [Abstract][Full Text] [Related]
32. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression. Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691 [TBL] [Abstract][Full Text] [Related]
33. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation. Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266 [TBL] [Abstract][Full Text] [Related]
34. Systemic treatment with neuropeptide Y receptor Y1-antagonist enhances atherosclerosis and stimulates IL-12 expression in ApoE deficient mice. Jääskeläinen AE; Seppälä S; Kakko T; Jaakkola U; Kallio J Neuropeptides; 2013 Apr; 47(2):67-73. PubMed ID: 23261359 [TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice. Bhaskar V; Yin J; Mirza AM; Phan D; Vanegas S; Issafras H; Michelson K; Hunter JJ; Kantak SS Atherosclerosis; 2011 Jun; 216(2):313-20. PubMed ID: 21411094 [TBL] [Abstract][Full Text] [Related]
36. The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE(-/-) mouse model. Gaspari T; Welungoda I; Widdop RE; Simpson RW; Dear AE Diab Vasc Dis Res; 2013 Jul; 10(4):353-60. PubMed ID: 23673376 [TBL] [Abstract][Full Text] [Related]
37. Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Ramos CL; Huo Y; Jung U; Ghosh S; Manka DR; Sarembock IJ; Ley K Circ Res; 1999 Jun; 84(11):1237-44. PubMed ID: 10364560 [TBL] [Abstract][Full Text] [Related]
38. Atorvastatin Upregulates the Expression of miR-126 in Apolipoprotein E-knockout Mice with Carotid Atherosclerotic Plaque. Pan X; Hou R; Ma A; Wang T; Wu M; Zhu X; Yang S; Xiao X Cell Mol Neurobiol; 2017 Jan; 37(1):29-36. PubMed ID: 26886754 [TBL] [Abstract][Full Text] [Related]
39. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Kaufmann BA; Sanders JM; Davis C; Xie A; Aldred P; Sarembock IJ; Lindner JR Circulation; 2007 Jul; 116(3):276-84. PubMed ID: 17592078 [TBL] [Abstract][Full Text] [Related]
40. In vivo evaluation of vascular-targeted spheroidal microparticles for imaging and drug delivery application in atherosclerosis. Namdee K; Thompson AJ; Golinski A; Mocherla S; Bouis D; Eniola-Adefeso O Atherosclerosis; 2014 Nov; 237(1):279-86. PubMed ID: 25286447 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]